Ann Clin Microbiol Antimicrob
Mo Farah explains why he changed story told to US anti-doping agency on taking L-carnitine Farah initially insisted he had never taken the substance, then returned to say that he had Bookmark CommentsGo to comments Sir Mo Farah has explained how he came to change his account when questioned in 2015 about taking supplement L-carnitine before the 2014 London Marathon
placebo, 80.4% (41/51)), and mean age (s.d.) was similar (apitegromab, 44.2 years (11.0)
[DOI] [PubMed] [Google Scholar] 105.Morgan J.F., Reid F., Lacey J.H
Molecular and cellular biochemistry, 244(1-2), 89-94
Excessive lipid accumulation in skeletal muscle cells, and the free fatty acids produced from their breakdown, inhibit glucose utilization in skeletal muscle (172)